Free Trial

Larimar Therapeutics (LRMR) News Today

$10.09
-0.49 (-4.63%)
(As of 07/17/2024 ET)
Larimar Therapeutics: More Data Still Needed
Larimar Therapeutics logo with Medical background
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Rating of "Buy" by Analysts
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) have been given a consensus recommendation of "Buy" by the six analysts that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-mont
Larimar Therapeutics logo with Medical background
Larimar Therapeutics (NASDAQ:LRMR) Sees Large Volume Increase
Larimar Therapeutics (NASDAQ:LRMR) Sees Strong Trading Volume
Larimar Therapeutics (NASDAQ:LRMR) Shares Up 4%
Larimar Therapeutics logo with Medical background
Larimar Therapeutics (NASDAQ:LRMR) Trading Up 4%
Larimar Therapeutics (NASDAQ:LRMR) Trading 4% Higher
Larimar Therapeutics logo with Medical background
Larimar Therapeutics (NASDAQ:LRMR) Stock Price Up 8.4%
Larimar Therapeutics (NASDAQ:LRMR) Trading Up 8.4%
Larimar Therapeutics logo with Medical background
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Recommendation of "Buy" by Brokerages
Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) has received a consensus rating of "Buy" from the six analysts that are presently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1 year price target among brokers t
Larimar Therapeutics (NASDAQ:LRMR) Trading Down 5.9%
Larimar Therapeutics (NASDAQ:LRMR) Shares Down 5.9%
Short Interest in Larimar Therapeutics, Inc. (NASDAQ:LRMR) Decreases By 17.6%
Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) was the recipient of a significant decrease in short interest in the month of May. As of May 31st, there was short interest totalling 3,220,000 shares, a decrease of 17.6% from the May 15th total of 3,910,000 shares. Based on an average trading volume of 515,900 shares, the days-to-cover ratio is currently 6.2 days.
Opaleye Management Inc. Reduces Position in Larimar Therapeutics, Inc. (NASDAQ:LRMR)
Opaleye Management Inc. cut its holdings in shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR - Free Report) by 26.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 623,500 shares of the company's sto
Verition Fund Management LLC Cuts Position in Larimar Therapeutics, Inc. (NASDAQ:LRMR)
Verition Fund Management LLC decreased its holdings in shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR - Free Report) by 3.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,811,131 shares of the company's stock after selling 8
Larimar Therapeutics (NASDAQ:LRMR) Shares Up 7.9%
Larimar Therapeutics (NASDAQ:LRMR) Trading 7.9% Higher
Larimar Therapeutics (NASDAQ:LRMR) Shares Gap Up to $7.10
Larimar Therapeutics (NASDAQ:LRMR) Shares Gap Up to $7.10
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Average Recommendation of "Buy" by Analysts
Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) has been assigned an average rating of "Buy" from the six research firms that are presently covering the company, MarketBeat reports. Six analysts have rated the stock with a buy rating. The average 12 month target price among brokerages t
Citigroup Raises Larimar Therapeutics (NASDAQ:LRMR) Price Target to $14.00
Citigroup raised their price target on Larimar Therapeutics from $10.00 to $14.00 and gave the company a "buy" rating in a report on Wednesday.
Larimar Therapeutics (NASDAQ:LRMR) Sees Unusually-High Trading Volume
Larimar Therapeutics (NASDAQ:LRMR) Sees Large Volume Increase
Larimar Therapeutics (NASDAQ:LRMR) Stock Rating Reaffirmed by JMP Securities
JMP Securities reissued a "market outperform" rating and issued a $25.00 target price on shares of Larimar Therapeutics in a research note on Tuesday.
Larimar Therapeutics (NASDAQ:LRMR) Shares Gap Up to $7.27
Larimar Therapeutics (NASDAQ:LRMR) Shares Gap Up to $7.27
Larimar Therapeutics (NASDAQ:LRMR) Trading 10.2% Higher
Larimar Therapeutics (NASDAQ:LRMR) Trading Up 10.2%
Larimar: Q1 Earnings Snapshot
Larimar Therapeutics (NASDAQ:LRMR) Shares Up 6%
Larimar Therapeutics (NASDAQ:LRMR) Shares Up 6%
Equities Analysts Set Expectations for Larimar Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:LRMR)
Larimar Therapeutics, Inc. (NASDAQ:LRMR - Free Report) - Stock analysts at Leerink Partnrs issued their Q1 2024 EPS estimates for shares of Larimar Therapeutics in a report issued on Wednesday, April 3rd. Leerink Partnrs analyst J. Park expects that the company will post earnings of ($0.25) per s
Equities Analysts Set Expectations for Larimar Therapeutics, Inc.'s FY2026 Earnings (NASDAQ:LRMR)
Larimar Therapeutics, Inc. (NASDAQ:LRMR - Free Report) - Investment analysts at Leerink Partnrs issued their FY2026 earnings estimates for shares of Larimar Therapeutics in a research report issued on Wednesday, April 3rd. Leerink Partnrs analyst J. Park forecasts that the company will post earni
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Rating of "Buy" from Brokerages
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) have been given a consensus recommendation of "Buy" by the five brokerages that are covering the company, MarketBeat reports. Five investment analysts have rated the stock with a buy rating. The average 12-month target price amon
Larimar Therapeutics (NASDAQ:LRMR) Earns "Outperform" Rating from Leerink Partnrs
Leerink Partnrs reiterated an "outperform" rating on shares of Larimar Therapeutics in a report on Wednesday.
Larimar Therapeutics (NASDAQ:LRMR) Shares Gap Up to $7.36
Larimar Therapeutics (NASDAQ:LRMR) Shares Gap Up to $7.36
Larimar Therapeutics (NASDAQ:LRMR) Research Coverage Started at SVB Leerink
SVB Leerink began coverage on shares of Larimar Therapeutics in a research note on Wednesday. They issued an "outperform" rating and a $25.00 price objective on the stock.
Larimar Therapeutics (NASDAQ:LRMR) Trading 8.1% Higher
Larimar Therapeutics (NASDAQ:LRMR) Trading 8.1% Higher
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Short Interest Up 221.6% in March
Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) saw a large increase in short interest in March. As of March 15th, there was short interest totalling 1,630,000 shares, an increase of 221.6% from the February 29th total of 506,800 shares. Based on an average trading volume of 570,900 shares, the days-to-cover ratio is currently 2.9 days.
JMP Securities Reiterates Market Outperform Rating for Larimar Therapeutics (NASDAQ:LRMR)
JMP Securities reissued a "market outperform" rating and set a $25.00 price objective on shares of Larimar Therapeutics in a research note on Friday.
Get Larimar Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LRMR and its competitors with MarketBeat's FREE daily newsletter.

[URGENT] Altcoin Winning Picks (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

LRMR Media Mentions By Week

LRMR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LRMR
News Sentiment

0.80

0.93

Average
Medical
News Sentiment

LRMR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LRMR Articles
This Week

4

2

LRMR Articles
Average Week

Get Larimar Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LRMR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:LRMR) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners